InvestorsHub Logo
Followers 27
Posts 665
Boards Moderated 0
Alias Born 04/30/2019

Re: CalMustang post# 202377

Friday, 07/19/2019 1:24:52 PM

Friday, July 19, 2019 1:24:52 PM

Post# of 426304
I have a feeling they raised now because they will or are planning to file an amendment to the sNDA and get a 3 month delay which will drop this another 10-15 percent.

I don’t buy the “they did it for GS and JPMorgan” argument. This was calculated and planned as evidenced by the “coincidental” timing of 10b5-1 plans which SHOULD be investigated by the SEC. 365 days in a year and the plan executes near the all time high of the stock? It’s laughable. And criminal.

I did research on stocks delayed by the fda due to amendments and the announcement can come 5 days prior or 40.

The plus side? Most were approved after new PDUFA date. Some of them haven’t reached the new date yet.

Here is an extension that was announced FIVE days before PDUFA date.

https://www.globenewswire.com/news-release/2019/06/06/1865633/0/en/Xeris-Pharmaceuticals-Receives-Notification-of-PDUFA-Date-Extension-for-Gvoke.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News